Emmanuel Mduma, Clinical Oncology Specialist at Rabininsia Memorial Hospital, Lecturer at Rabininsia University, shared on LinkedIn:
“It was a meaningful experience to present our early clinical experience with Trastuzumab deruxtecan in selected patients in Tanzania during the RENATA PLC experience-sharing session held in Madrid in 2026.
The presentation provided an opportunity to share clinical insights while highlighting the importance of continued real-world evidence generation and equitable access to innovative cancer therapies in Tanzania.”
You can also read: Trastuzumab Deruxtecan Approved in China for HER2-Positive Early Breast Cancer With Residual Disease
